fatty liver. Other specified inflammatory liver diseases
Conditions
Interventions
Intervention 1: symbiotic and vitamin E placebo supplement. Intervention 2: symbiotic and vitaminE supplement. Intervention 3: symbiotic placebo and vitaminE supplement. Intervention 4: symbiotic and
Treatment - Other
Treatment - Drugs
Placebo
symbiotic and vitamin E placebo supplement
symbiotic and vitaminE supplement
symbiotic placebo and vitaminE supplement
symbiotic and placebo of vitaminE
Sponsors
Office of the Presidential Scholars Fund
Eligibility
Sex/Gender
All
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: inclusion criteria: age of 20-50;BMI= 25-35;having fatty liver based on blood test and sonography;interesting in participation in research; without any metabolic disease , CHD, diabetes , cancer; without infection disease in research ;without allergy for cow s milk; no smoking ; no alcoholism; without immune system suppressor drugs 6 mounts before research; no menstrual bleeding ;without any diet 2 mounts before research ;no consumption food supplementation during research exclusion criteria: metabolic disease , CHD, diabetes , autoimmune disease , cancer; infection disease in research ; allergy for cow s milk; smoking ; alcoholism; immune system suppressor drugs 6 mounts before research; menstrual bleeding; diet 2 mounts before research; lactose deficiency; food supplementation during research; no interesting for participation
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Waist circumference. Timepoint: before and after of intervention. Method of measurement: meter.;Fat percent. Timepoint: befor and after of intervention. Method of measurement: BIA method.;Weight. Timepoint: before and after of intervention. Method of measurement: digital scaling.;BMI. Timepoint: before and after of intervention. Method of measurement: calculation.;Systolic blood presure. Timepoint: before and after of intervention. Method of measurement: barometer.;Diastolic blood presure. Timepoint: before and after of intervention. Method of measurement: barometer.;ALT. Timepoint: before and after of intervention. Method of measurement: serum Measurement.;AST. Timepoint: before and after of intervention. Method of measurement: serum Measurement.;GGT. Timepoint: before and after of intervention. Method of measurement: serum measurement.;NOS. Timepoint: before and after of intervention. Method of measurement: serum measurement.;TNFa. Timepoint: before and after of intervention. Method of measurement: serum measurement.;MDA. Timepoint: before and after of intervention. Method of measurement: serum measurment.;Insulin. Timepoint: before and after of intervention. Method of measurement: serum measurement.;Leptin. Timepoint: before and after of intervention. Method of measurement: serum measurement.;Glucose. Timepoint: before and after of intervention. Method of measurement: blood measurement.;HDL. Timepoint: before and after of intervention. Method of measurement: plasma measurement.;LDL. Timepoint: before and after of intervention. Method of measurement: plasma measurement.;TG. Timepoint: before and after of intervention. Method of measurement: serum measurement.;Cholesterol. Timepoint: before and after of intervention. Method of measurement: plasma measurement.;ApoB100. Timepoint: before and after of intervention. Method of measurement: plasma maesurement.;ApoA1. Timepoint: before and after of intervention. Method of measurement: plasma measurement.;Bilirubin. Timepo | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactdr. Farzad Shidfar
Tehran University of Medical Science
Outcome results
None listed